We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

EUROIMMUN AG

Euroimmun (part of Revvity) is an international provider of medical laboratory products for autoimmune, infection, al... read more Featured Products: More products

Download Mobile App




Automated Microscope Classifies IIF Patterns in Autoimmune Dermatoses

By LabMedica International staff writers
Posted on 02 May 2023

Autoimmune bullous dermatoses (AIBD) are a diverse group of autoantibody-driven conditions characterized by blistering and erosion of the skin and mucous membranes, including pemphigus diseases, pemphigoid diseases, and dermatitis herpetiformis. More...

Differentiating between disease sub-types is essential for making treatment decisions. Indirect immunofluorescence (IIF) microscopy using tissue sections of the esophagus and salt-split skin is one of the most sensitive screening methods for initially differentiating AIBD. IIF on esophagus identifies autoantibodies against epithelial and endomysial antigens, while IIF on salt-split skin differentiates autoantibodies against the basement membrane zone. However, interpreting the complex IIF patterns can be challenging and is not well standardized.

In a joint study, scientists at EUROIMMUN (Lübeck, Germany) and the University of Lübeck (Lübeck, Germany) have developed and assessed a computer-aided system for classifying IIF patterns on esophagus and salt-split skin samples. The scientists created the training datasets by incubating biochip slides containing millimeter-sized tissue sections with various dilutions of patient serum samples and controls. Subsequently, the team used the EUROPattern Microscope 1.5 to acquire images. The results of the computer-aided evaluation were compared with findings from manual evaluations by experienced IIF technicians.

Automated IIF evaluation on esophagus and salt-split skin presents a challenge, as the small structures necessary for classification are only present in certain areas of the tissue substrates. Standard deep networks are not suitable for processing these images due to computer memory limitations and the number of available training images. Consequently, the researchers employed segmentation to focus the classification networks on the essential regions. The developed algorithms demonstrated high accuracy for pattern classification on esophagus and salt-split skin, with over 95% agreement with visual reading results. The positive predictive agreement was above 97% for all positive IF patterns on both tissue substrates, while the negative predictive agreement was at least 95% for all patterns.

The researchers concluded that deep networks can be adapted for evaluating complex tissue substrates by incorporating the segmentation of relevant regions into the prediction process. These classifiers offer an excellent enhancement to AIBD screening methods and can reduce the workload for professionals when interpreting tissue sections in IIF testing.

Related Links:
EUROIMMUN 
University of Lübeck 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.